Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2010
10/06/2010CN101849969A Application of butyric acid producing beneficial bacterium in preparing preparation for preventing and treating severe disease gut barrier injury and post-injury complication
10/06/2010CN101849962A Lipid-lowering and weight-losing complex nutrient preparation and preparation method thereof
10/06/2010CN101849961A Compound electrolyte medicine composition injection
10/06/2010CN101849960A Conjugated linoleic acid combination preparation and preparation method thereof
10/06/2010CN101849950A Application of rotundic acid in preparing blood lipid regulating medicines
10/06/2010CN101849944A Medicinal composition for treating type 2 diabetes
10/06/2010CN101849935A Sesamin/episesamin compositions
10/06/2010CN101849933A Conjugated linoleic acid ferrite preparation and preparation method thereof
10/06/2010CN101849932A Nutrient preparation of iron and zinc and preparation method thereof
10/06/2010CN101849919A N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same
10/06/2010CN101417130B Medicine combination for treating II type diabetes and complicating diseases thereof
10/06/2010CN101361907B Hypoglycemic, antihypertensive formulation and preparation technique thereof
10/06/2010CN101293065B Biological proprietary Chinese medicine for preventing and treating diabetes
10/06/2010CN101199553B Preparing method for treating diabetes whole silkworm powder
10/06/2010CN101181461B Chinese medicine emplastrum for slimming and removing fat
10/06/2010CN101130774B Nucleotide molecule SR5B and its application in preparation of antidiabetic medicine
10/06/2010CN101130773B Nucleotide molecule SR5B2 and its application in preparation of antidiabetic medicine
10/06/2010CN101057942B External applied medicine ointment for treating diabetes foot and its preparing method
10/06/2010CN101040911B Chinese traditional medicine capsule preparation for treating and preventing diabetes and the method of preparing the same
10/06/2010CN101040905B Medicine made by selfheal for reducing blood sugar
10/06/2010CN101019909B Supercritical safflower extracting process
10/05/2010US7807795 Antibodies to osteoprotegerin binding proteins
10/05/2010US7807780 Multi-component biological transport systems
10/05/2010US7807712 Oxy substituted chalcones as antihyperglycemic and antidyslipidemic agents
10/05/2010US7807701 Dibenzylamine compounds and pharmaceutical use thereof
10/05/2010US7807700 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/05/2010US7807689 such as 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile, used for the treatment of breast cancer and non-insulin depepndent diabetes
10/05/2010US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders
10/05/2010US7807674 such as 2-[3,5-Dichloro-4-(5-isopropyl-1-methyl-6-oxo-1,6-dihydro-pyridazin-3-ylmethyl)-phenyl]-3,5-dioxo-2,3,4,5-tetrahydro-[1,2,4]triazine-6-carbonitrile, useful for the treatment of obesity, hyperlipemia, hypercholesterolemia, diabetes, fatty liver, atherosclerosis, cancer and cardiovascular disorders
10/05/2010US7807663 Therapeutic agents for diabetes
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010US7807655 uridine-5'-monophosphate or cytidine-5'-monophosphate for the treatment of affections of the peripheral nervous system, particularly polyneuropathies, neuritides, and myopathies; for stimulating the regeneration of nerves
10/05/2010US7807430 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening
10/05/2010US7807390 G-protein coupled receptor ligands and methods
10/05/2010US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents
10/05/2010CA2441331C Bicyclic guanidine derivatives and therapeutic uses thereof
10/05/2010CA2393297C Polyhydroxystilbenes as antipsoriatic agents and protein kinase inhibitors
10/05/2010CA2364245C Water soluble group ia and iia double metal salt of(-)- hydroxycitric acid
10/05/2010CA2332000C Phytosterol compositions
09/2010
09/30/2010WO2010111665A1 Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
09/30/2010WO2010111527A1 Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
09/30/2010WO2010110640A1 Anti-diabetic nutraceutical composition from palm leaf extract
09/30/2010WO2010110479A1 Activator for peroxisome proliferator-activated receptor
09/30/2010WO2010110440A1 Novel therapeutic agent for cognitive impairment
09/30/2010WO2010110374A1 Agent for enhancing hypoglycemic activity
09/30/2010WO2010110026A1 Pharmaceutical composition for metabolic syndrome, obesity, hyperglycemia, hyperlipemia and/or fatty liver
09/30/2010WO2010109042A1 Composition for the prevention or treatment of diabetes mellitus
09/30/2010WO2010108950A1 Use of a probiotic to regulate body weight
09/30/2010WO2010108937A2 Drug fusions and conjugates
09/30/2010WO2010108903A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010108865A1 Use of probiotics to ameliorate diet-induced insulin resistance
09/30/2010WO2010108408A1 Composition of traditional chinese medicine for reducing blood fat and preparation method thereof
09/30/2010WO2010108314A1 Use of fiber pentose or composition containing fiber pentose in manufacture of foods or medicines for preventing and/or treating acidification in diabetic patient
09/30/2010WO2010108268A1 Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/30/2010WO2010108262A1 TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC β-CELL DYSFUNCTION
09/30/2010WO2010091185A3 Inhibitors of fructose 1,6-bisphosphatase and methods of use thereof
09/30/2010WO2010008831A3 Compounds and methods for modulating g protein-coupled receptors
09/30/2010US20100249248 LIGAND AGENTS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPARs)
09/30/2010US20100249243 Novel beta-hydroxyketones and beta-alkoxyketones with estrogenic activity
09/30/2010US20100249241 N,n-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
09/30/2010US20100249235 Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome
09/30/2010US20100249228 Sarms and method of use thereof
09/30/2010US20100249224 Methods and compositions for modulating glutamate dehydrogenase
09/30/2010US20100249217 Modulators of pharmacological agents
09/30/2010US20100249207 Synthesis of pyrrolidine compounds
09/30/2010US20100249206 Modified lysine-mimetic compounds
09/30/2010US20100249204 Calcium salts of indole derived statins
09/30/2010US20100249192 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/30/2010US20100249189 Nitric oxide donor compounds
09/30/2010US20100249183 Therapeutic use of n-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives
09/30/2010US20100249174 Ccr1 antagonists and methods of use therefor
09/30/2010US20100249171 Ellipticine compounds for treating obesity
09/30/2010US20100249165 Pdz domain modulators
09/30/2010US20100249161 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes
09/30/2010US20100249155 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
09/30/2010US20100249151 Imidazo 1, 2-a pyrimidine derivatives for the treatment of diseases such as diabetes
09/30/2010US20100249148 Novel pyrimidine compounds having benzyl (heterocyclic methyl) amine structure and medicament comprising the same
09/30/2010US20100249147 Sulfonyl-substituted 6-membered ring derivative
09/30/2010US20100249146 Heteroaryloxy quinazoline derivative
09/30/2010US20100249144 Substituted piperazines as cb1 antagonists
09/30/2010US20100249140 Solid state forms of sitagliptin salts
09/30/2010US20100249139 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249137 Novel sEH Inhibitors and Their Use
09/30/2010US20100249128 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
09/30/2010US20100249124 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249118 Compounds and methods for kinase modulation, and indications therefor
09/30/2010US20100249098 Oxypiperidine derivatives and methods of use thereof
09/30/2010US20100249097 Novel substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
09/30/2010US20100249095 Substituted Spiro-amide Compounds
09/30/2010US20100249093 Substituted Heteroarylpiperidine Derivatives As Melanocortin-4 Receptor Modulators
09/30/2010US20100249092 Heteroaryl compounds and uses thereof
09/30/2010US20100249087 Compounds as cannabinoid receptor ligands
09/30/2010US20100249086 Compounds As Cannabinoid Receptor Ligands
09/30/2010US20100249084 Substituted pyrimidines as adenosine receptor antagonists
09/30/2010US20100249082 Modulators of hypoxia inducible factor-1 and related uses
09/30/2010US20100249081 Compositions and methods for treatment of renal disease
09/30/2010US20100249079 Analogues of cilostazol
09/30/2010US20100249078 Tetracyclic inhibitors of fatty acid amide hydrolase
09/30/2010US20100249074 Benzyl-cycloalkyl sphingosine 1-phosphate receptor modulators
09/30/2010US20100249046 Novel mangiferin calcium salts, the method for its preparation and its use
1 ... 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 ... 1298